BIOMAT Database Logo BIOMAT Database Logo

Synthesis, in vitro anticancer and antimycobacterial evaluation of new 5-(2,5-dimethoxyphenyl)-1,3,4-thiadiazole-2-amino derivatives. 2015

Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
Centre for Chemical Sciences and Technology, IST, Jawaharlal Nehru Technological University Hyderabad, Kukatpally, Hyderabad 500085, T.S., India.

A series of 2,5-disubstituted-1,3,4-thiadiazole derivatives 5a-5l, 7a-7e and 9 have been synthesised and screened for in vitro antimycobacterial activity against Mycobacterium smegmatis MC-155. In addition these compounds have also been screened for cytotoxic activity against cancer cell lines HT-29, MDA-MB-231 by MTT colorimetric assay. The compounds are well characterized by spectral analysis viz. (1)H NMR, (13)C NMR, FT-IR, mass and HRMS. Screening results indicate that compounds 5g, 7a possess good antitubercular activity with MIC value 65.74 and 40.86, respectively, compounds 5g, 7a, 7b, 7d, 7e and 9 displayed promising cytotoxic activity against the cell lines tested. 5g and 7a stand out to be potent antimycobacterial and anticancer agents among the tested series. Further the title compounds were also tested on human normal cells HEK293T and are found to be safer with lesser cytotoxicity. It is interesting to observe that compound 5g has come out to be safer, potent anticancer and antimycobacterial agent.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
Synthesis and evaluation of in vitro antimycobacterial activity of some 5-(5-nitro-2-thienyl)-2-(piperazinyl, piperidinyl and morpholinyl)-1,3,4-thiadiazole derivatives.
November 2003, Bollettino chimico farmaceutico,
Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
Synthesis of 3-(3,4-dimethoxyphenyl)-1 H-1,2,4-triazole-5-thiol and 2-amino-5-(3,4-dimethoxyphenyl)-1,3,4-thiadiazole derivatives exhibiting anti-inflammatory activity.
August 2001, Die Pharmazie,
Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
Synthesis of 1,3,4-Thiadiazole Derivatives and Their Anticancer Evaluation.
December 2023, International journal of molecular sciences,
Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
[Derivatives of 2-amino-5-cyclopentyl-1,3,4-thiadiazole].
January 1971, Il Farmaco; edizione scientifica,
Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
2-Amino-5-methyl-1,3,4-thiadiazole and 2-amino-5-ethyl-1,3,4-thiadiazole.
October 2001, Acta crystallographica. Section C, Crystal structure communications,
Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
[Synthesis of 2(or 2,5-di)-substituted-1,3,4-thiadiazole derivatives].
October 1965, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
5-(Thiophen-2-yl)-1,3,4-thiadiazole derivatives: synthesis, molecular docking and in vitro cytotoxicity evaluation as potential anticancer agents.
January 2018, Drug design, development and therapy,
Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
1,3,4-thiadiazole derivatives. Part 9. Synthesis and biological activity of metal complexes of 5-(2-aminoethyl)-2-amino-1,3,4-thiadiazole.
January 1996, Metal-based drugs,
Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
Synthesis and anticancer evaluation of novel 2-cyclopropylimidazo[2,1-b][1,3,4]-thiadiazole derivatives.
September 2011, European journal of medicinal chemistry,
Naveen Polkam, and Parsharamulu Rayam, and Jaya Shree Anireddy, and Satyanarayana Yennam, and Hasitha Shilpa Anantaraju, and Sriram Dharmarajan, and Yogeeswari Perumal, and Sudha Sravanti Kotapalli, and Ramesh Ummanni, and Sridhar Balasubramanian
Synthesis, characterization, antimicrobial, and pharmacological evaluation of some 2, 5-disubstituted sulfonyl amino 1,3,4-oxadiazole and 2-amino-disubstituted 1,3,4-thiadiazole derivatives.
October 2014, Journal of advanced pharmaceutical technology & research,
Copied contents to your clipboard!